Gsa Capital Partners LLP Immatics N.V. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Immatics N.V. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 12,557 shares of IMTX stock, worth $74,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,557Holding current value
$74,588% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.1MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$87.2 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$55.7 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$54.3 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$51 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$43.2 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $453M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...